
TSE:MFC
De-risked US business, the weakest unit. He's looking at it, on shopping list, hasn't yet pulled trigger. Re-rated nicely, undemanding multiple, single-digit PE ratio. Yield is ~4%. Pay attention to chart validating fundamental changes, often a leading indicator of changes within. Wouldn't quarrel with investors taking a position.
Cheaper PE at 8.5x than peers, decent growth rate of 9%. Nice beat recently with Asia up 21%, EPS up 18%, ROE starting to get higher at 16.7%. Helped by rates being higher for longer. Insurance companies still better than the banks, and fund flows continue. Nice yield of 4.5%, with 8% growth.
Ideally, he'd like to buy lower. But can still buy here and it will work for your portfolio over the next 1-2 years.
It is at its highest level in a year. It has 3 major features: top line growth, margin expansion and dividend growth. It is getting out of long term care which is a catalyst. Growing at 9.3% and trading at 9X it is still cheaper than its group. He considers it better than the banks. Lower rates will help with their charges.
(Analysts’ price target is $39.19)Buy 12 Hold 5 Sell 0